CDK1 and neoplasm: The top upregulated genes of these categories in R1 cells included CDK1, CDC25A, BLM, and AURKB. CDK1 and CDC25A force proliferation despite drug-induced DNA damage, due to their ability to completely disable cell-cycle checkpoints [20,21], and are therefore associated with tumor progression and drug resistance [22].